Tengen Biomedical Co
Bethesda, United States · Founded 2017 · $3.0M raised
- Headquarters
- Bethesda, Maryland
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Total Funding
- $3.0M
- Last Round
- $3.0M GrantJan 2017
- Rounds
- 1
About
Tengen Biomedical is a vaccine and biological drug development company focused on DNA recombinant vaccine platforms for infectious diseases and cancer. The company has received NIH SBIR/STTR grants for development of dengue and Zika virus vaccines using pseudoinfectious virus technology. It operates internationally with units in Maryland, Beijing, Shanghai, and Hong Kong.
Summary
Tengen Biomedical Co is a Biotech company based in Bethesda, United States, founded in 2017. It has raised $3.0M in total across 1 round, most recently a $3.0M Grant round in Jan 2017. Investors include National Institute of Allergy and Infectious Diseases.
Funding History
Jan 2017
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/tengen-biomedical-co"><img src="https://indexed.vc/api/badge/company/tengen-biomedical-co" alt="Tengen Biomedical Co on Indexed.vc" width="260" height="76" /></a>